Azido-PEG4-Glu-Val-Cit-PAB-MMAE

Azido-PEG4-Glu-Val-Cit-PAB-MMAE Catalog number: BADC-01349

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Azido-PEG4-Glu-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC.

Category
ADCs Cytotoxin with Linkers
Product Name
Azido-PEG4-Glu-Val-Cit-PAB-MMAE
Catalog Number
BADC-01349
Molecular Formula
C74H120N14O20
Molecular Weight
1525.85

Ordering Information

Catalog Number Size Price Quantity
BADC-01349 -- $-- Inquiry
Description
Azido-PEG4-Glu-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC.
IUPAC Name
(S)-1-azido-17-(((S)-1-(((S)-1-((4-((5S,8S,11S,12R)-11-((S)-sec-butyl)-12-(2-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradecyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamoyl)-15-oxo-3,6,9,12-tetraoxa-16-azaicosan-20-oic acid
InChI
InChI=1S/C74H120N14O20/c1-15-48(8)64(57(102-13)43-59(90)88-34-20-24-56(88)66(103-14)49(9)67(94)79-50(10)65(93)52-21-17-16-18-22-52)86(11)72(99)62(46(4)5)84-71(98)63(47(6)7)87(12)74(101)108-44-51-25-27-53(28-26-51)80-68(95)54(23-19-32-77-73(75)100)82-70(97)61(45(2)3)83-69(96)55(29-30-60(91)92)81-58(89)31-35-104-37-39-106-41-42-107-40-38-105-36-33-78-85-76/h16-18,21-22,25-28,45-50,54-57,61-66,93H,15,19-20,23-24,29-44H2,1-14H3,(H,79,94)(H,80,95)(H,81,89)(H,82,97)(H,83,96)(H,84,98)(H,91,92)(H3,75,77,100)/t48-,49+,50+,54-,55-,56-,57+,61-,62-,63-,64-,65+,66+/m0/s1
InChIKey
AMAAMBUISINHTD-GAFGRBKHSA-N

Azido-PEG4-Glu-Val-Cit-PAB-MMAE is a chemical conjugate used extensively in targeted cancer therapies. Here are some key applications of Azido-PEG4-Glu-Val-Cit-PAB-MMAE:

Antibody-Drug Conjugates (ADCs): Azido-PEG4-Glu-Val-Cit-PAB-MMAE is a critical linker-payload component in the development of ADCs. These conjugates consist of monoclonal antibodies specific to cancer cell antigens, linked to cytotoxic drugs via the Azido-PEG4-Glu-Val-Cit-PAB-MMAE linker. Upon binding to the cancer cell, the ADC is internalized and the cytotoxic drug is released, killing the cell while sparing healthy tissues.

Directed Drug Delivery: This conjugate is engineered for targeted drug delivery, enhancing the selective toxicity of chemotherapeutic agents. The PEGylation ensures increased solubility and stability, while the Val-Cit dipeptide ensures the payload is released specifically in the presence of tumor-specific proteases. This strategy minimizes systemic side effects and improves therapeutic efficacy.

Cell Imaging and Tracking: Azido-PEG4-Glu-Val-Cit-PAB-MMAE can be utilized in advanced cell imaging techniques. By tagging specific cells with this conjugate, researchers can track and image the distribution and proliferation of these cells in real-time. This application is critical for understanding tumor dynamics and the pharmacokinetics of therapeutic interventions.

Pharmacokinetic Studies: Researchers use Azido-PEG4-Glu-Val-Cit-PAB-MMAE in pharmacokinetic and biodistribution studies to assess the behavior of new drug candidates in the body. By conjugating drugs to this linker-payload, scientists can study how drugs are absorbed, distributed, metabolized, and excreted. These insights are vital for optimizing dosage regimens and improving drug safety profiles.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Resources & Supports
Inquiry Basket